← Open Payments lookup

RACHEL ROYLANCE: Open Payments

NPI 1770095432 · LONGVIEW, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,574 in 113 payments from 36 companies in 2025. Trend: 2023 $2,025 · 2024 $2,475 · 2025 $2,574

Food & beverage: $2,460Education: $114
CompanyPaymentsAmount
Amgen Inc.13$281
AstraZeneca Pharmaceuticals LP13$276
ABBVIE INC.14$263
Astellas Pharma US Inc5$160
Alkermes, Inc.2$152
Lilly USA, LLC7$147
Viatris Specialty LLC6$139
GlaxoSmithKline, LLC.7$115
Novartis Pharmaceuticals Corporation4$112
Salix Pharmaceuticals, a division of Bausch Health US, LLC6$98

Products named: AIRSUPRA, EVENITY, VRAYLAR, YUPELRI, LYBALVI, TRELEGY ELLIPTA, OTEZLA, LEQVIO.

Industry payments across WA — which companies pay providers there.